Previous Article | Next Article 
Journal of Clinical Microbiology, April 2008, p. 1498-1500, Vol. 46, No. 4
0095-1137/08/$08.00+0 doi:10.1128/JCM.02117-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Validation of the BrockTB Stat-Pak Assay for Detection of Tuberculosis in Eurasian Badgers (Meles meles) and Influence of Disease Severity on Diagnostic Accuracy
Mark A. Chambers,1*
Tim Crawshaw,2
Sue Waterhouse,3
Richard Delahay,4
R. Glyn Hewinson,1 and
Konstantin P. Lyashchenko5
TB Research Group, Department of Statutory and Exotic Bacterial Diseases, Veterinary Laboratories Agency Weybridge, New Haw, Surrey KT15 3NB, United Kingdom,1
Veterinary Laboratories Agency Starcross, Staplake Mount, Exeter, Devon EX6 8PE, United Kingdom,2
Veterinary Laboratories Agency Langford, Bristol BS40 5DX, United Kingdom,3
Central Science Laboratory, Sand Hutton, York YO4 1LZ, United Kingdom,4
Chembio Diagnostic Systems, Inc., Medford, New York 117635
Received 2 November 2007/
Accepted 4 February 2008

ABSTRACT
A lateral-flow immunoassay (BrockTB Stat-Pak) for detecting
tuberculosis in Eurasian badgers was 49% sensitive and 93% specific
against culture for
M. bovis (
n = 1,464) at necropsy. However,
the sensitivity was significantly higher (66 to 78%) in animals
with more severe tuberculosis, indicating that the BrockTB Stat-Pak
may be useful for the detection of badgers with the greatest
risk of transmitting disease.

TEXT
Despite attempts to control bovine tuberculosis (TB), the average
incidence of disease in cattle in Great Britain increased an
estimated 225% between the years 1996 and 2006 (
7), causing
considerable economic loss to the government and the farming
community. In parts of Great Britain and Ireland, Eurasian badger
(
Meles meles) populations constitute a reservoir of infection
with
Mycobacterium bovis and a potential source of infection
to cattle (
8,
14,
15). In an effort to simplify the serodetection
of badger TB, we developed a lateral-flow immunoassay (
13) that
is now manufactured as the BrockTB Stat-Pak assay (Chembio Diagnostic
Systems, Inc., Medford, NY). We report here the results of ongoing
evaluation of the assay, in particular the influence of disease
severity on diagnostic accuracy.
Badger sera were obtained in Great Britain from two sources and stored frozen at –20°C until testing (i) 1,464 animals killed as part of the defra/Independent Scientific Group Randomized Badger Culling Trial (RBCT) (8) and (ii) 68 animals captured, sampled, and then released as part of an ongoing ecological and epidemiological study in Woodchester Park (WP), southwest England (6). Each badger from the RBCT was subjected to routine necropsy examination and culture for the presence of M. bovis. Carcasses were stored at 4°C and examined by a standardized necropsy protocol within 3 days of submission. A range of tissues and lymph nodes were examined for evidence of TB. In badgers with no lesions the bronchial, mediastinal, and retropharyngeal lymph nodes were placed in 1% cetyl-pyridinium chloride prior to bacterial culture. In badgers with lesions the lesion tissue was always submitted for culture. Bite wounds were sampled separately. Tissues were processed within 72 h of sampling. The cetyl-pyridinium chloride was discarded, and the tissues were rinsed in saline and then emulsified before inoculation onto six slopes of modified Middlebrook 7H11 agar. The slopes were incubated at 37 ± 2°C. Any growth of organisms characteristic of mycobacteria was identified by spoligotyping (9). The infection status of WP badgers was determined by bacterial culture of clinical samples of feces, urine, sputum, pus from abscesses, and bite wound swabs as described previously (3).
Compared to the culture results from tissues taken at necropsy (n = 1,464), the findings were as follows: BrockTB Stat-Pak positive, culture negative, n = 74; BrockTB Stat-Pak negative, culture negative, n = 1,004; BrockTB Stat-Pak positive, culture positive, n = 190; and BrockTB Stat-Pak negative, culture positive, n = 196. Thus, the BrockTB Stat-Pak had a sensitivity for detection of TB of 49.2% (95% confidence interval [CI] = 44.1 to 54.4%) and a specificity of 93.1% (95% CI = 91.4 to 94.6%). These figures are within the ranges previously reported by us with a smaller sample size (13) and are equivalent to the performance of the existing serum enzyme-linked immunosorbent assay-based test for TB (Brock Test) (2, 5, 12). Although the specificity was relatively high, this is likely to be an underestimate. The badgers were sampled from parts of the country where TB is endemic, and it is likely that true infection was missed in some cases despite the use of an extensive postmortem culture protocol.
During the present study, samples that were hemolyzed and/or lipemic were identified prior to testing. Although previous work showed that the condition of these samples did not influence the Brock Test (unpublished data), the potential effect on the performance of the BrockTB Stat-Pak was unknown. A total of 216 RBCT serum samples from the 1,464 submitted to testing (14.8%) were either hemolyzed or lipemic. Compared to "normal" samples, those that were hemolyzed and/or lipemic exhibited a statistically significant reduction in sensitivity (P = 0.003, Fisher exact test), but no difference in specificity (P = 0.613, Fisher exact test) (Table 1).
Subdivision of culture-positive badgers based on criteria associated
with disease severity revealed an increased ability of the BrockTB
Stat-Pak to detect infected badgers with more severe (progressed,
disseminated) disease (Table
2). By inference, these individuals
may pose a greater risk of infecting other badgers and cattle
through repeated and/or greater excretion of
M. bovis (
4,
10).
However, it must be borne in mind that the relationship between
pathology in the badger and the likelihood of onward transmission
of TB is unknown. Two criteria were used to identify such animals:
either their "excretor status" (for WP badgers, which were live
sampled and then released) or presentation of gross lesions
at necropsy (for RBCT badgers). The BrockTB Stat-Pak detected
25 of 32 so-called "super-excretor" WP badgers, representing
a sensitivity of 78.1% (95% CI = 60.0 to 90.7%). An animal was
classified as a "super-excretor" after its second consecutive
culture positive result or after it had provided two positive
culture results from different samples (e.g., feces and urine)
on its last sampling occasion (
6). In addition, "super-excretors"
have a higher mortality rate (
17) and so probably represent
animals with progressive TB that does not resolve. In contrast,
"excretors" exhibit intermittent shedding or may apparently
cease bacterial excretion altogether (
6). The BrockTB Stat-Pak
detected 15 of 36 "excretor" badgers, representing a sensitivity
of 41.7% (95% CI = 25.5 to 59.3%). The difference in the sensitivity
of TB detection between "super-excretor" and excretor
badgers was highly significant (
P = 0.003, Fisher exact test),
a finding consistent with our previous observation that seropositivity
in badgers was associated with more severe disease (
1). Similarly,
the BrockTB Stat-Pak detected 66.1% of culture-positive badgers
with visible lesions suspicious of TB at necropsy (VL) compared
to only 34.4% of those with no suspect TB lesions at necropsy
(NVL) (Table
2). The difference in sensitivity was again highly
significant (
P < 0.0001, Fisher exact test). We have recently
demonstrated improved detection rates of TB in the badger using
quantitative real-time PCR (
16) and an enzyme immunoassay (
5)
to detect the antigen-specific production of gamma interferon
(IFN-

). For both the IFN-

enzyme immunoassay and the Brock Test,
the sensitivity was also significantly higher in badgers with
VL than in those with NVL (
5). However, the Brock Test and both
IFN-

tests require specialist laboratory facilities and equipment
and take 3 and 48 h, respectively, to complete. In contrast,
the BrockTB Stat-Pak can be performed anywhere and produces
a result in no more than 20 min.
The BrockTB Stat-Pak had the lowest sensitivity in culture-positive
NVL badgers, which would be consistent with the suggestion that
this group is proportionally less likely to be excreting
M. bovis (
10). Moreover, not all VL badgers will excrete
M. bovis,
since this will depend on the anatomical location of the lesion,
its structure, and the quantity of bacteria contained therein
(
10,
11). This is consistent with the lower sensitivity of the
BrockTB Stat-Pak for VL badgers than that seen for "super-excretors."
Overall, these data are consistent with a positive BrockTB Stat-Pak
test result being more frequently associated with advanced TB,
especially that which gives rise to more extensive or persistent
shedding of bacteria.
In summary, the BrockTB Stat-Pak is an easily executed and rapid test for the detection of TB in badgers. The BrockTB Stat-Pak could be performed directly in the field, although consideration should be given to the quality of the blood sample so that test sensitivity is not adversely affected. With a sensitivity of 49% compared to the "gold standard" of necropsy tissue culture, the BrockTB Stat-Pak is unlikely to be sufficiently sensitive for routine TB surveillance. However, the sensitivity was significantly higher in animals with more severe TB, classified by more frequent excretion of M. bovis or the presence of visible lesions at necropsy. This raises the possibility that the BrockTB Stat-Pak could be of use where a simple tool is required to detect badgers more likely to be at advanced stages of disease.

ACKNOWLEDGMENTS
We acknowledge financial support from the Department for Environment,
Food, and Rural Affairs (defra), United Kingdom, and the assistance
of Paul Upton, Centre for Epidemiology and Risk Analysis, Veterinary
Laboratories Agency (VLA), for provision of the RBCT data.
All work with animals was conducted under licenses issued by the Home Office, United Kingdom, following ethical clearance by the VLA and CSL.

FOOTNOTES
* Corresponding author. Mailing address: TB Research Group, Department of Statutory and Exotic Bacterial Diseases, Veterinary Laboratories Agency Weybridge, New Haw, Surrey KT15 3NB, United Kingdom. Phone: 44 1932 357 494. Fax: 44 1932 357 260. E-mail:
m.a.chambers{at}vla.defra.gsi.gov.uk 
Published ahead of print on 13 February 2008. 

REFERENCES
1 - Chambers, M. A., W. A. Pressling, C. L. Cheeseman, R. S. Clifton-Hadley, and R. G. Hewinson. 2002. Value of existing serological tests for identifying badgers that shed Mycobacterium bovis. Vet. Microbiol. 86:183-189.[CrossRef][Medline]
2 - Clifton-Hadley, R. S., A. R. Sayers, and M. P. Stock. 1995. Evaluation of an ELISA for Mycobacterium bovis infection in badgers (Meles meles). Vet. Rec. 137:555-558.[Abstract]
3 - Clifton-Hadley, R. S., J. W. Wilesmith, and F. A. Stuart. 1993. Mycobacterium bovis in the European badger (Meles meles): epidemiological findings in tuberculous badgers from a naturally infected population. Epidemiol. Infect. 111:9-19.[Medline]
4 - Corner, L. A. 2006. The role of wild animal populations in the epidemiology of tuberculosis in domestic animals: how to assess the risk. Vet. Microbiol. 112:303-312.[CrossRef][Medline]
5 - Dalley, D., D. Davé, S. Lesellier, S. Palmer, T. R. Crawshaw, R. G. Hewinson, and M. A. Chambers. Development and evaluation of a gamma-interferon enzyme immunoassay for tuberculosis in European badgers (Meles meles). Tuberculosis, in press.
6 - Delahay, R. J., S. Langton, G. C. Smith, R. S. Clifton-hadley, and C. L. Cheeseman. 2000 The spatio-temporal distribution of Mycobacterium bovis (bovine tuberculosis) infection in a high-density badger population. J. Anim. Ecol. 69:428-441.[CrossRef]
7 - Department for Environment, Food, and Rural Affairs. 2007. Animal Heath 2006: The Report of the Chief Veterinary Officer. Department for Environment, Food and Rural Affairs, London, United Kingdom.
8 - Donnelly, C. A., G. Wei, W. T. Johnston, D. R. Cox, R. Woodroffe, F. J. Bourne, C. L. Cheeseman, R. S. Clifton-Hadley, G. Gettinby, P. Gilks, H. E. Jenkins, A. M. Le Fevre, J. P. McInerney, and W. I. Morrison. 2007. Impacts of widespread badger culling on cattle tuberculosis: concluding analyses from a large-scale field trial. Int. J. Infect. Dis. 11:300-308.[CrossRef][Medline]
9 - Durr, P. A., R. G. Hewinson, and R. S. Clifton-Hadley. 2000. Molecular epidemiology of bovine tuberculosis. I. Mycobacterium bovis genotyping. Rev. Sci. Technol. 19:675-688.[Medline]
10 - Gallagher, J., R. Monies, M. Gavier-Widen, and B. Rule. 1998. Role of infected, non-diseased badgers in the pathogenesis of tuberculosis in the badger. Vet. Rec. 142:710-714.[Abstract/Free Full Text]
11 - Gavier-Widen, D., M. A. Chambers, N. Palmer, D. G. Newell, and R. G. Hewinson. 2001. Pathology of natural Mycobacterium bovis infection in European badgers (Meles meles) and its relationship with bacterial excretion. Vet. Rec. 148:299-304.[Abstract/Free Full Text]
12 - Goodger, J., A. Nolan, W. P. Russell, D. J. Dalley, C. J. Thorns, F. A. Stuart, P. Croston, and D. G. Newell. 1994. Serodiagnosis of Mycobacterium bovis infection in badgers: development of an indirect ELISA using a 25 kDa antigen. Vet. Rec. 135:82-85.[Abstract]
13 - Greenwald, R., J. Esfandiari, S. Lesellier, R. Houghton, J. Pollock, C. Aagaard, P. Andersen, R. G. Hewinson, M. Chambers, and K. Lyashchenko. 2003. Improved serodetection of Mycobacterium bovis infection in badgers (Meles meles) using multiantigen test formats. Diagn. Microbiol. Infect. Dis. 46:197-203.[CrossRef][Medline]
14 - Griffin, J. M., D. H. Williams, G. E. Kelly, T. A. Clegg, I. O'Boyle, J. D. Collins, and S. J. More. 2005. The impact of badger removal on the control of tuberculosis in cattle herds in Ireland. Prev. Vet. Med. 67:237-266.[CrossRef][Medline]
15 - Krebs, J., R. Anderson, T. Clutton-Brock, I. Morrison, D. Young, and C. Donnelly. 1997. Bovine tuberculosis in cattle and badgers: report by the Independent Scientific Review Group. Ministry of Agriculture, Fisheries, and Food, London, United Kingdom.
16 - Sawyer, J., D. Mealing, D. Dalley, D. Dave, S. Lesellier, S. Palmer, J. Bowen-Davies, T. R. Crawshaw, and M. A. Chambers. 2007. Development and evaluation of a test for tuberculosis in live European badgers (Meles meles) based on measurement of gamma interferon mRNA by real-time PCR. J. Clin. Microbiol. 45:2398-2403.[Abstract/Free Full Text]
17 - Wilkinson, D., G. C. Smith, R. J. Delahay, L. M. Rogers, C. L. Cheeseman, and R. S. Clifton-Hadley. 2000. The effects of bovine tuberculosis (Mycobacterium bovis) on mortality in a badger (Meles meles) population in England. J. Zool. 250:389-395.[CrossRef]
Journal of Clinical Microbiology, April 2008, p. 1498-1500, Vol. 46, No. 4
0095-1137/08/$08.00+0 doi:10.1128/JCM.02117-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Greenwald, R., Lyashchenko, O., Esfandiari, J., Miller, M., Mikota, S., Olsen, J. H., Ball, R., Dumonceaux, G., Schmitt, D., Moller, T., Payeur, J. B., Harris, B., Sofranko, D., Waters, W. R., Lyashchenko, K. P.
(2009). Highly Accurate Antibody Assays for Early and Rapid Detection of Tuberculosis in African and Asian Elephants. CVI
16: 605-612
[Abstract]
[Full Text]
-
Drewe, J. A., Dean, G. S., Michel, A. L., Pearce, G. P.
(2009). Accuracy of three diagnostic tests for determining Mycobacterium bovis infection status in live-sampled wild meerkats (Suricata suricatta). jvdi
21: 31-39
[Abstract]
[Full Text]
-
Harrington, N. P., Surujballi, O. P., Prescott, J. F., Duncan, J. R., Waters, W. R., Lyashchenko, K., Greenwald, R.
(2008). Antibody Responses of Cervids (Cervus elaphus) following Experimental Mycobacterium bovis Infection and the Implications for Immunodiagnosis. CVI
15: 1650-1658
[Abstract]
[Full Text]